The Relative Strength (RS) Rating for EverQuote climbed into a new percentile Thursday, with an increase from 76 to 82.
Looking For The Best Stocks To Buy And Watch? Start Here
IBD's proprietary RS Rating tracks technical performance by showing how a stock's price movement over the last 52 weeks measures up against that of the other stocks in our database.
History reveals that the best stocks tend to have an 80 or better RS Rating in the early stages of their moves.
EverQuote is trying to complete a consolidation with a 30.03 buy point. See if the stock can break out in volume at least 40% above average.
Earnings growth picked up last quarter from 0% to 320%. But revenue gains fell from 165% to 83%.
EverQuote earns the No. 3 rank among its peers in the Insurance-Diversified industry group. Palomar Holdings is the No. 1-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
